Literature DB >> 15068257

Patient reported outcomes as endpoints in medical research.

Diane L Fairclough1.   

Abstract

This review covers a number of the many design and analytic issues associated with clinical trials that incorporate patient reported outcomes as primary or secondary endpoints. We use a clinical trial designed to evaluate a new therapy for the prevention of migraines to illustrate how endpoints are defined by the objectives of the study, the methods for handling longitudinal assessments with multiple scales or outcomes, and the methods of analysis in the presence of missing data.

Entities:  

Mesh:

Year:  2004        PMID: 15068257     DOI: 10.1191/0962280204sm357ra

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  25 in total

Review 1.  Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments.

Authors:  Satoshi Morita; Adrian A Kaptein; Akira Tsuburaya; Yasuhiro Kodera; Takanori Matsui; Junichi Sakamoto
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

2.  Handling missing quality of life data in HIV clinical trials: what is practical?

Authors:  Diane L Fairclough; Herbert Thijs; I-Chan Huang; Henrik W Finnern; Albert W Wu
Journal:  Qual Life Res       Date:  2007-12-11       Impact factor: 4.147

3.  Does aggressive hydration reverse the effects of pneumoperitoneum on renal perfusion?

Authors:  S V Demyttenaere; L S Feldman; S Bergman; S Gholoum; C Moriello; B Unikowsky; S Fraser; F Carli; G M Fried
Journal:  Surg Endosc       Date:  2005-12-09       Impact factor: 4.584

4.  Physicians' Use of Patients' Daily Reports of Quality of Life to Evaluate Treatment Response in Phase I Cancer Trials.

Authors:  Felicity W K Harper; Elisabeth I Heath; Marci E J Gleason; Louis Penner; Patricia Lorusso; Ding Wang; Terrance L Albrecht
Journal:  J Cancer Ther       Date:  2012-10

5.  Feasibility and acceptability of a decision aid designed for people facing advanced or terminal illness: a pilot randomized trial.

Authors:  Dan D Matlock; Tarah A E Keech; Marlene B McKenzie; Michael R Bronsert; Carolyn T Nowels; Jean S Kutner
Journal:  Health Expect       Date:  2011-10-28       Impact factor: 3.377

6.  Health-related quality of life in patients with advanced colorectal cancer: results from a phase II study of S-1 combined with irinotecan (CPT-11).

Authors:  Akira Tsunoda; Naokuni Yasuda; Kentaro Nakao; Kazuhiro Narita; Makoto Watanabe; Nobuaki Matsui; Yuko Tsunoda; Mitsuo Kusano
Journal:  Int J Clin Oncol       Date:  2010-03-16       Impact factor: 3.402

7.  Statistical controversies in cancer research: using standardized effect size graphs to enhance interpretability of cancer-related clinical trials with patient-reported outcomes.

Authors:  M L Bell; M H Fiero; H M Dhillon; V J Bray; J L Vardy
Journal:  Ann Oncol       Date:  2017-08-01       Impact factor: 32.976

8.  Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities.

Authors:  Ethan Basch; David Artz; Alexia Iasonos; John Speakman; Kevin Shannon; Kai Lin; Charmaine Pun; Henry Yong; Paul Fearn; Allison Barz; Howard I Scher; Mary McCabe; Deborah Schrag
Journal:  J Am Med Inform Assoc       Date:  2007-02-28       Impact factor: 4.497

9.  Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders.

Authors:  Florence Tubach; Philippe Ravaud; Dorcas Beaton; Maarten Boers; Claire Bombardier; David T Felson; Desireé van der Heijde; George Wells; Maxime Dougados
Journal:  J Rheumatol       Date:  2007-05       Impact factor: 4.666

10.  A clinical perspective on electronically collecting patient-reported outcomes at the point-of-care for overactive bladder.

Authors:  Darren Desantis; Richard J Baverstock; Andrea Civitarese; R Trafford Crump; Kevin V Carlson
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.